| Literature DB >> 31064149 |
Shengyu Liu1, Linping Hu2, Dong Jiang3, Wanpeng Xi4,5.
Abstract
To investigate the effect of post-harvest light irradiation on the accumulation of flavonoids and limonoids, harvested Newhall navel oranges were continuously exposed to light-emitting diode (LED) and ultraviolet (UV) light irradiation for 6 days, and the composition and content of flavonoids and limonoids in the segments were determined using UPLC-qTOF-MS at 0, 6, and 15 days after harvest. In total, six polymethoxylated flavonoids (PMFs), five flavone-O/C-glycosides, seven flavanone-O-glycosides, and three limonoids were identified in the segments. The accumulation of these components was altered by light irradiation. Red and blue light resulted in higher levels of PMFs during exposure periods. The accumulation of PMFs was also significantly induced after white light, UVB and UVC irradiation were removed. Red and UVC irradiation induced the accumulation of flavone and flavanone glycosides throughout the entire experimental period. Single light induced limonoid accumulation during exposure periods, but limonoid levels decreased significantly when irradiation was removed. Principal component analysis showed a clear correlation between PMFs and white light, between flavonoid glycosides and red light and UVC, and between limonoids and UVC. These results suggest that the accumulation of flavonoids and limonoids in citrus is regulated by light irradiation. White light, red light and UVC irradiation might be a good potential method for improving the nutrition and flavor quality of post-harvest citrus.Entities:
Keywords: LED; Newhall navel oranges; PMFs; UVs; flavonoid glucosides; limonoids
Mesh:
Substances:
Year: 2019 PMID: 31064149 PMCID: PMC6540038 DOI: 10.3390/molecules24091755
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Summary of the 21 compounds identified.
| Retention Time (min) | Component Name | Formula | [M + H]+ (Error, ppm) | Diagnostic MS2 Ion (%) | Structure | CAS Registry Number | Health-Promoting Properties |
|---|---|---|---|---|---|---|---|
| 3.36 | Apigenin-6,8-di- | C27H30O15 | 595.16592 (0.29) | 595.16565 (100), 325.07041 (74.91), 457.11183 (68.54), 379.08087 (67.98), 409.09118 (48.64), 477.11946 (2.90) |
| 23666-13-9 | Anti-prostate cancer [ |
| 3.59 | Diosmetin 6,8-di- | C28H32O16 | 625.17556 (−1.20) | 625.17448 (100), 355.07895 (97.31), 487.12160 (76.16), 409.09206 (75.73), 457.11214 (63.68), 367.08299 (55.83), 607.16286 (25.34) |
| 98813-28-6 | Antioxidant; Antihypertensive effect [ |
| 3.69 | Rhoifolin-4′- | C33H40O19 | 741.22360 (−0.07) | 433.11258 (71.19), 271.05979 (68.12), 595.16594 (59.59), 153.01818 (9.23), 163.03854 (6.68) |
| 31498-83-6 | Not found |
| 3.71 | Neoeriocitrin(Flavanone | C27H32O15 | 597.17996 (−2.41) | 289.07002 (35.39), 153.01818 (9.23), 435.12045 (6.36), 451.12259 (4.27) |
| 13241-32-2 | Anti-osteoporosis [ |
| 3.76 | Chysoeriol-6,8-di- | C28H32O16 | 625.17571 (−0.96) | 285.07510 (3.29), 457.10814 (3.07), 355.07804 (2.69), 367.07961 (1.65), 487.12086 (1.53), 607.16347 (0.48) |
| 63975-58-6 | DNA-binding activity [ |
| 3.78 | Narirutin-4′-glucoside(Flavanone | C33H42O19 | 743.23932 (−0.02) | 273.07568 (100), 765.22083 (35.37), 153.01801 (18.88), 147.04375 (6.36), 435.12831 (18.31) |
| 17257-22-6 | Antioxidant [ |
| 4.34 | Epilimonin(Limonoid) | C26H30O8 | 471.20201 (1.41) | 471.20151(100), 425.19591 (75.41), 161.05961 (32.74), 409.20043 (12.39), 315.15814 (3.13), 273.12685 (1.79) |
| 1180-71-8 | Not found |
| 4.68 | Eriocitrin(Flavanone | C27H32O15 | 597.18124 (−0.26) | 289.07048 (100), 153.01781 (34.16), 163.03866 (19.72), 417.12444 (7.56), 435.12720 (7.19) |
| 13463-28-0 | Anti-obesity [ |
| 5.65 | Narirutin(Flavanone | C27H32O14 | 581.18661 (0.22) | 273.07588 (100), 329.15998 (0.04), 153.01794 (29.66), 493.04405 (0.49), 419.13333 (18.54) |
| 15822-82-9 | Anti-inflammation [ |
| 6.26 | Diosmin(Flavone | C28H32O15 | 609.18126 (−0.22) | 301.07027(100), 463.12343(18.13), 286.04676(11.08), 258.05273(10.79) |
| 520-27-4 | Antidiabetic [ |
| 6.41 | Hesperidin(Flavanone | C28H34O15 | 611.19777 (1.18) | 303.08637 (100), 449.14389 (27.63), 153.01803 (23.49), 177.05451 (17.19), 465.13864 (13.85) |
| 520-26-3 | Antioxidant; Anti-inflammation; Anticancer; Anti-atherosclerotic effects; Vasodilatation effects [ |
| 6.75 | Neohesperidin(Flavanone | C28H34O15 | 611.19631 (−1.20) | 303.086432 (100), 359.01192 (4.22), 153.01814 (41.50), 345.10040 (9.97) |
| 13241-33-3 | Anti-gastric disease [ |
| 6.85 | 7α-Limonyl acetate(Limonoid) | C28H34O9 | 515.22775 (0.37) | 515.22780 (100), 161.05954 (22.10), 303.08669 (2.38), 487.23253 (28.24), 469.22182 (17.67) |
| 1110-03-8 | Hsp90 inhibition activity [ |
| 8.99 | Didymin(Flavanone | C28H34O14 | 595.20210 (−0.05) | 287.09139 (100), 153.01808 (29.95), 389.12180 (0.26), 161.05957 (12.80), 433.14904 (16.67) |
| 14259-47-3 | Anticancer [ |
| 10.41 | 5,7,8,3′,4′-Pentamethoxyflavone(Isosinensetin) (Polymethoxylated flavone) | C20H20O7 | 373.12780 (−1.01) | 343.08079 (100), 373.12755 (41.38), 315.08636 (19.74), 357.09485 (15.26), 153.06825 (11.84), 181.08895 (8.36) |
| 17290-70-9 | Anticancer [ |
| 11.06 | 5,6,7,3′,4′-Pentamethoxyflavone(Sinensetin) (Polymethoxylated flavone) | C20H20O7 | 373.12819 (0.02) | 343.08115 (100), 373.12778 (86.23), 312.09888 (58.65), 358.10324 (25.10), 153.01835 (9.06), 163.07473 (5.57) |
| 2306-27-6 | Anti-inflammation; Anticancer [ |
| 11.18 | Limonin(Limonoid) | C26H30O8 | 471.20110 (−0.51) | 343.08084 (100), 328.05373 (6.03), 161.06004 (7.74), 395.10636 (8.58), 425.19653 (6.58) |
| 23885-43-0 | Inhibit HIV-1 replication [ |
| 11.95 | 5,6,7,8,3′,4′-Hexamethoxyflavone(Nobiletin) (Polymethoxylated flavone) | C21H22O8 | 403.13818 (−1.40) | 373.09128 (100), 403.13793 (30.35), 388.11432 (12.31), 327.08555 (10.22), 211.02312 (4.26), 183.02844 (3.77) |
| 478-01-3 | Anti-inflammation; Anticancer; Anti-atherosclerotic effects; Anti-diabetic effects [ |
| 12.03 | 5,7,8,4’-Tetramethoxyflavone(Polymethoxylated flavone) | C19H18O6 | 343.11751 (−0.30) | 313.07010 (100), 282.08813 (68.95), 343.11731 (54.57), 153.01802 (13.31), 181.01279 (6.96), 133.06470(6.08) |
| 6601-66-7 | Not found |
| 12.58 | 3,5,6,7,8,3′,4′-Heptamethoxyflavone(Polymethoxylated flavone) | C22H24O9 | 433.14855 (−1.75) | 403.10148 (100), 433.14821 (44.27), 373.05410 (5.31), 404.10479 (23.30), 418.12464 (15.15), 385.09043(10.56) |
| 1178-24-1 | Anti-inflammation; Anti-atherosclerotic effects [ |
| 13.02 | 5,6,7,8,4′-Pentamethoxyflavone(Tangeretin) (Polymethoxylated flavone) | C20H20O7 | 373.12765 (−1.42) | 343.08087 (100), 395.10987 (3.85), 373.12802 (20.26), 344.08433 (20.73), 297.07575 (10.69), 211.02316 (6.07) |
| 481-53-8 | Antioxidant; Anti-inflammation; Anticancer; Anti-atherosclerotic effects; Anti-diabetic effects [ |
Figure 1Mass chromatogram of apigenin-6,8-di-C-glucoside (Vicenin-2) in positive (a) low-energy and (b) high-energy modes.
Figure 2MS response of PMFs in the segments of Newhall navel orange during light irradiation and the removal period.
Figure 3MS response of flavone and flavanone in the segments of Newhall navel orange during light irradiation and during the removal period. Flavone and flavanone (a) were mostly induced by red light, (b) UVC, and were also (c) induced by UV and darkness.
Figure 4MS response of limonoids in the segments of Newhall navel orange during light irradiation and during the removal period.
Figure 5PCA model based on 21 phytochemicals in Newhall navel orange in response to different forms of light irradiation. DK: Dark; WL: White light; BL: Blue light; RL: Red light; UVA: Ultraviolet A; UVB: Ultraviolet B; UVC: Ultraviolet C; d: Days after harvest.